1. Home
  2. Live Updates
  3. Clarus ventures

Live Breaking News & Updates on Clarus ventures

Stay informed with the latest breaking news from Clarus ventures on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Clarus ventures and stay connected to the pulse of your community

ChromaCode Names Chairman

Carlsbad-based genomics technology developer ChromaCode announced this morning that it has named Mark McDonough as Chairman. McDonough is the company's current CEO, and joined the company a year ago. Th

Carol-gallagher , Credit-suisse , Piper-jaffray , Blackstone-life-sciences , Mark-mcdonough , Michele-park , Clarus-ventures ,

Avillion announces US approval of AstraZeneca's Airsupra (PT027) as new rescue treatment for asthma

Avillion announces US approval of AstraZeneca's Airsupra (PT027) as new rescue treatment for asthma
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Sacramento , California , United-states , Canada , United-kingdom , Treasure-island , London , City-of , American , Allison-jeynes , George-underwood , Astrazeneca-airsupra

Avillion LLP: Avillion announces US approval of AstraZeneca's Airsupra (PT027) as new rescue treatment for asthma

Airsupra is the first and only rescue medication approved in the US for as-needed use to reduce risk of asthma exacerbations Approval based on successful Phase III trial programme conducted

Canada , Sacramento , California , United-states , United-kingdom , Treasure-island , London , City-of , American , Allison-jeynes , George-underwood , Astrazeneca-airsupra

J.P. Morgan Launches New Life Sciences Private Capital Team - News

J.P. Morgan Asset Management announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team will invest in both early and growth stage healthcare companies across multiple strategies aligned to specific market opportunities, with a focus on novel therapeutics and technologies in several target areas...

New-york , United-states , Dana-farber-cancer-institute , Massachusetts , Cornell-university , Harvard-university , Columbia-university , American , Stephen-oesterle , Laurie-glimcher , Frederic-moll , George-gatch

J.P. Morgan Launches New Life Sciences Private Capital Team Targeting Investments in Innovative Healthcare Companies

/PRNewswire/ -- J.P. Morgan Asset Management today announced the launch of a new life sciences private equity team, Life Sciences Private Capital. The new team...

New-york , United-states , Dana-farber-cancer-institute , Massachusetts , Cornell-university , Harvard-university , Columbia-university , American , Stephen-oesterle , Laurie-glimcher , Frederic-moll , Prnewswirejp-morgan

Avillion LLP: US FDA accepts New Drug Application filed by Avillion for AstraZeneca's PT027 for the as-needed treatment or prevention of symptoms in asthma patients

Results from Phase III trials conducted by Avillion in over 4,000 patients show that PT027, a novel fixed-dose combination of albuterol and budesonide, significantly reduced the risk of a severe

London , City-of , United-kingdom , United-states , Canada , American , Allison-jeynes , George-underwood , Drug-administration , American-thoracic-society-international-conference , Prnewswire-avillion , Astrazeneca

US FDA accepts New Drug Application filed by Avillion for AstraZeneca's PT027 for the as-needed treatment or prevention of symptoms in asthma patients

/PRNewswire/ -- Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical candidates from proof-of-concept through...

London , City-of , United-kingdom , United-states , Canada , American , Allison-jeynes , George-underwood , Pharmaand-abingworth , Drug-administration , American-thoracic-society-international-conference , Prnewswire-avillion

BioSpace Movers & Shakers: Jeffrey Leiden, Don Hayden, Zentalis, Entera and More

Life sciences organizations and companies strengthen their leadership teams and boards with these Movers & Shakers.

Boston , Massachusetts , United-states , Maryland , Texas , Anthony-sun , James-foster , Glympse-bio , Eli-lilly , Margaret-gilmour , Virax-biolabs , Sanjay-zaveri

Odyssey Therapeutics Appoints Industry Leader Jeffrey M. Leiden, M.D., Ph.D., as Board Chair

/PRNewswire/ -- Odyssey Therapeutics, Inc., a biotechnology company pioneering next generation precision immunomodulators and oncology medicines, today...

Boston , Massachusetts , United-states , Harvard-school-of-public-health , American , Garyd-glick , Vertex-pharmaceuticals , Elkanr-blout-professor-of-biological-sciences , Harvard-medical-school , American-academy-of-arts , Professor-of-medicine-at-harvard-medical-school

Cancer drug startup draws former Vertex CEO to board

BioPharma

Gary-glick , Reshma-kewalramani , Abbott-laboratories , Dive-brief , Executive-chairman-jeffrey-leiden , Clarus-ventures , Tmunity-therapeutics , Biotech ,